# A Study to Evaluate Adverse Events and Change in Disease Activity of Intravenous ABBV-706 Versus Standard of Care in Adult Participants With Relapsed/Refractory Small Cell Lung Cancer

> clinical trial · VERIFIED · 2026-08-14

Status: RECRUITING · Sponsor: AbbVie · Condition: Small Cell Lung Cancer

- Company: AbbVie
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT07365241

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.